Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

Abstract Introduction Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL‐ENIGMA study explored the effect of Souvenaid on synapse function in early AD...

Full description

Saved in:
Bibliographic Details
Main Authors: Nienke M.E. Scheltens, Casper T. Briels, Maqsood Yaqub, Frederik Barkhof, Ronald Boellaard, Wiesje M. van derFlier, Lothar A. Schwarte, Charlotte E. Teunissen, Amos Attali, Laus M. Broersen, Bart N.M. vanBerckel, Philip Scheltens
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Online Access:https://doi.org/10.1016/j.trci.2019.08.002
Tags: Add Tag
No Tags, Be the first to tag this record!